Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Cameli

Showing results (11-20 of 183) with videos related to

Pageof 19
Sort By:
Journal of Medical Virology|August 16, 2020
Serum concentrations of Krebs von den Lungen-6 in different COVID-19 phenotypesMiriana d'Alessandro, Paolo Cameli, Laura Bergantini, et al.
Frontiers in Pharmacology|March 21, 2022
Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping ReviewLaura Bergantini, Alessandro Mainardi, Miriana d'Alessandro, et al.
Immunity, Inflammation and Disease|January 14, 2025
Regulatory T Cell Phenotype Related to Cytokine Expression Patterns in Post-COVID-19 Pulmonary Fibrosis and Idiopathic Pulmonary FibrosisSara Gangi, Laura Bergantini, Irene Paggi, et al.
Journal of Medical Virology|October 2, 2020
Peripheral biomarkers' panel for severe COVID-19 patientsMiriana d'Alessandro, Laura Bergantini, Paolo Cameli, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 31, 2023
The effect of anti-IL5 monoclonal antibodies on regulatory and effector T cells in severe eosinophilic asthmaLaura Bergantini, Tommaso Pianigiani, Miriana d'Alessandro, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|March 27, 2026
Combined use of serum KL-6 and respiratory functional parameters for identifying fibrotic lung damage in SARS-CoV-2-induced interstitial pneumoniaMiriana D'Alessandro, Irene Paggi, Giusy Montuori, et al.
Panminerva Medica|April 16, 2020
Serum CD59: a novel biomarker of idiopathic pulmonary fibrosis?Paolo Cameli, Laura Bergantini, Miriana D'Alessandro, et al.
Antioxidants (Basel, Switzerland)|September 28, 2021
Alveolar Nitric Oxide as a Biomarker of COVID-19 Lung Sequelae: A Pivotal StudyPaolo Cameli, Elena Bargagli, Laura Bergantini, et al.
Life (Basel, Switzerland)|February 25, 2022
Neutrophil Extracellular Traps in ANCA-Associated Vasculitis and Interstitial Lung Disease: A Scoping ReviewMiriana d'Alessandro, Edoardo Conticini, Laura Bergantini, et al.
Cytokine|January 22, 2022
Cytokine profiles in the detection of severe lung involvement in hospitalized patients with COVID-19: The IL-8/IL-32 axisLaura Bergantini, Miriana d'Alessandro, Paolo Cameli, et al.
Pageof 19

Showing results (11-20 of 183) with videos related to

Sort By:
Pageof 19
Journal of Medical Virology|August 16, 2020
Serum concentrations of Krebs von den Lungen-6 in different COVID-19 phenotypesMiriana d'Alessandro, Paolo Cameli, Laura Bergantini, et al.
Frontiers in Pharmacology|March 21, 2022
Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping ReviewLaura Bergantini, Alessandro Mainardi, Miriana d'Alessandro, et al.
Immunity, Inflammation and Disease|January 14, 2025
Regulatory T Cell Phenotype Related to Cytokine Expression Patterns in Post-COVID-19 Pulmonary Fibrosis and Idiopathic Pulmonary FibrosisSara Gangi, Laura Bergantini, Irene Paggi, et al.
Journal of Medical Virology|October 2, 2020
Peripheral biomarkers' panel for severe COVID-19 patientsMiriana d'Alessandro, Laura Bergantini, Paolo Cameli, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 31, 2023
The effect of anti-IL5 monoclonal antibodies on regulatory and effector T cells in severe eosinophilic asthmaLaura Bergantini, Tommaso Pianigiani, Miriana d'Alessandro, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|March 27, 2026
Combined use of serum KL-6 and respiratory functional parameters for identifying fibrotic lung damage in SARS-CoV-2-induced interstitial pneumoniaMiriana D'Alessandro, Irene Paggi, Giusy Montuori, et al.
Panminerva Medica|April 16, 2020
Serum CD59: a novel biomarker of idiopathic pulmonary fibrosis?Paolo Cameli, Laura Bergantini, Miriana D'Alessandro, et al.
Antioxidants (Basel, Switzerland)|September 28, 2021
Alveolar Nitric Oxide as a Biomarker of COVID-19 Lung Sequelae: A Pivotal StudyPaolo Cameli, Elena Bargagli, Laura Bergantini, et al.
Life (Basel, Switzerland)|February 25, 2022
Neutrophil Extracellular Traps in ANCA-Associated Vasculitis and Interstitial Lung Disease: A Scoping ReviewMiriana d'Alessandro, Edoardo Conticini, Laura Bergantini, et al.
Cytokine|January 22, 2022
Cytokine profiles in the detection of severe lung involvement in hospitalized patients with COVID-19: The IL-8/IL-32 axisLaura Bergantini, Miriana d'Alessandro, Paolo Cameli, et al.
Pageof 19